Ignatiadis, M., Xenidis, N., Perraki, M., Apostolaki, S., Politaki, E., Kafousi, M., Stathopoulos, E.N., Stathopoulou, A., Lianidou, E., Chlouverakis, G., Sotiriou, C., Georgoulias, V. and Mavroudis, D. (2007) Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer. Journal of Clinical Oncology, 25, 5194-5202. doi10.1200/JCO.2007.11.7762 - References

Journals by Subject

Publish with us

Follow SCIRP

	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Article citationsMore>>

Ignatiadis, M., Xenidis, N., Perraki, M., Apostolaki, S., Politaki, E., Kafousi, M., Stathopoulos, E.N., Stathopoulou, A., Lianidou, E., Chlouverakis, G., Sotiriou, C., Georgoulias, V. and Mavroudis, D. (2007) Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer. Journal of Clinical Oncology, 25, 5194-5202. doi:10.1200/JCO.2007.11.7762

has been cited by the following article:

TITLE: MUC2 mRNA detection in peripheral blood and bone marrow of breast cancer patients reveals micrometastasis

AUTHORS: Negar Khazan, Ardeshir Ghavamzadeh, Anna S. Boyajyan, Gohar M. Mkrtchyan, Kamran Alimoghaddam, Seyed H. Ghaffari

KEYWORDS: Circulating Tumor Cells; Breast Cancer; MUC2; Real-Time PCR; Micrometastasis

JOURNAL NAME: Natural Science, Vol.5 No.1, January 15, 2013

ABSTRACT: Tumor dissemination to distant organ is the main cause of death. Therefore there is urgent need to set up sensitive methods for early detection of circulating tumor cells (CTCs) and disseminated tumor cells (DTCs) in peripheral blood (PB) and bone marrow (BM) specimens of breast cancer patients. We aim to detect MUC2 mRNA positive cells in PB and BM of breast cancer patients; to relate this to patient relapse. In this study to detect MUC2 mRNA positive cells (tumor marker), PB and BM samples were collected from 50 breast cancer patients after operation and before adjuvant therapy with 20 PB from healthy individuals as negative controls. Chi-square test was used to analyze data. MUC2 mRNA by using Real-time PCR was detected in 9 (18%) of PB and in 10 (20%) of BM samples and none of the healthy individuals. The relapse rate among MUC2-positive patients was significance in BM (P

Open Access

Articles

Formation of X-120 M Line Pipe through J-C-O-E Technique

Jai Dev Chandel, Nand Lal Singh

Engineering Vol.3 No.4, April 8, 2011

DOI: 10.4236/eng.2011.34046
Open Access

Articles

Detection of Estrogen Responsive Breast Cancer Circulating Tumor Cells: Assay Development for Anti-Hormone Therapy Resistance

Sally A. Litherland, Louis Barr, Robert Reynolds, Elizabeth Griffith, Ryan Sause, Tiffany Encarnacion, Alvin J. O. Almodovar, Xiang Zhu, Stephanie Dickstein, Yai-Ping Shao, Na’im Fanaian, David A. Decker

Journal of Cancer Therapy Vol.6 No.9, August 24, 2015

DOI: 10.4236/jct.2015.69085
Open Access

Articles

Complementing the Lagrangian Density of the E. M. Field and the Surface Integral of the p-v Vector Product

Mirwais Rashid

Applied Mathematics Vol.2 No.2, February 25, 2011

DOI: 10.4236/am.2011.22024
Open Access

Articles

Prognostic Value of Lymphocyte Vascular Density and E-Cadherin in Inflammatory Breast Cancer

Paul H. Levine, Heather J. Hoffman, Audra MacNeil, Salman Hashmi, Sherry X. Yang, Stephen Hewitt, Kenneth L. van Golen, Sandra M. Swain

Journal of Cancer Therapy Vol.5 No.14, December 3, 2014

DOI: 10.4236/jct.2014.514139
Open Access

Articles

Optimization of M/M/s/N Queueing Model with Reneging in a Fuzzy Environment

Ananda Prasad Panta, Ram Prasad Ghimire, Dinesh Panthi, Shankar Raj Pant

American Journal of Operations Research Vol.11 No.3, May 12, 2021

DOI: 10.4236/ajor.2021.113008

Follow SCIRP

	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journals by Subject

Publish with us

Article citationsMore>>

Home

About SCIRP

Service

Policies